GU ASCO annual meeting featured a kidney cancer trials in progress session and a presentation by Dr. Eric Jonasch discussing a phase 1b/2 study of combination 177Lu girentuximab + cabozantinib and ...

The human sense of touch is a complex system that integrates diverse sensations such as pain, temperature, and pleasant ...

Measles is a highly contagious disease, preventable by vaccines, which can cause serious illness or death. According to the CDC, measles was considered eliminated in 2000, meaning that "there is no ...

Although CAR T-cell therapies have been found effective against certain difficult-to-treat malignancies, they are not devoid of safety concerns.

Meet the jumbo phage. Scientists believe they’ve cracked the code on how its ‘secret handshakes’ act as a shield against the ...

Allogene Therapeutics (ALLO) announced the publication of data from its Phase 1 ALPHA and ALPHA2 clinical studies of cemacabtagene ...

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

“We’re in the mode of trailblazing the breakthroughs to move them closer to automotive applications,” Siyu Huang, the CEO of ...

The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).

Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...

John B. Amos Cancer Center at Piedmont Columbus Regional ’s midtown medical complex is the first in Georgia to offer this ...